In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
Enlarged microscopic image of blue-green immune cells surrounding one blue cancer cell.
Q&A
Immunotherapy Offers New Strategy for Treating Sarcoma

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.
MSK researcher in a lab
MSK Research Highlights, August 24, 2023

New MSK research suggests a method for revealing DNA repair “scars” could help make treatment decisions in BRCA1- and BRCA2-deficient cancers; modified a bacteria-made compound to target mutant KRAS-driven cancers; and shed new light on brain metastasis in non-small cell lung cancer.
msk patient christopher jeter and his wife connie
You’ve Finished Cancer Treatment. Now What? MSK’s Survivorship Program Provides Expert Care

Meet Christopher Jeter, who was diagnosed nearly 10 years ago with lung cancer. He was successfully treated at Memorial Sloan Kettering and now is being closely monitored by experts in MSK's Adult Survivorship Program.
Allison Betof Warner uses a pipette in the lab
Multiplying the Army of Cancer-Fighting Immune Cells

Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level.
Piro Lito, Bob Li, and Neal Rosen in the lab
In the Clinic
Promising Results from the First-Ever Trial of a Drug that Blocks Cancer Gene KRAS

The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.
David Hyman and Robin Gillespie
Finding
#AACR17: Basket Trial for Experimental Drug Shows Promising Early Results

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.
A scientist holding a tube in a lab
Sloan Kettering Institute Year in Review: 10 Noteworthy Science Breakthroughs of 2021

Take a look back at some of the biggest science stories from this past year.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023

New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Head and Neck Surgeon Benjamin Roman seen talking with MSK colleagues.
A Second Opinion Can Reduce Cancer Costs and Improve Care

Learn how a second opinion at a highly specialized cancer center such as MSK can lead to treatment that costs less and improves quality of life and survival.
A scientist pipetting in a lab
MSK Research Highlights, March 9, 2023

New research from MSK offers new proof-of-concept compounds against acute myeloid leukemia; reports results from a phase 1 clinical trial appraising two drugs against low- grade glioma; examines MSK’s first-in-the-nation program integrating herbal medicine into oncology care; and identifies how high-grade histologic patterns in lymph node metastases could better predict lung cancer outcomes.